fludarabine has been researched along with Leukemia L 1210 in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (75.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montgomery, JA; Secrist, JA; Shortnacy, AT | 1 |
| King, I; Li, Z; Liu, L; Song, BL; Zheng, LM | 1 |
| Brockman, RW; Cheng, YC; Montgomery, JA; Schabel, FM | 1 |
| Cory, JG; Montgomery, JA; Sato, A | 1 |
| Chello, PL; Dorick, DM; Montgomery, JA; Sirotnak, FM | 1 |
| Chello, PL; Dorick, DM; Montgomery, JA; Sirotnak, FM; Yang, CH | 1 |
| Bennett, LL; Brockman, RW; Shaddix, SC; White, EL | 1 |
| Brockman, RW; El Dareer, SM; Hill, DL; Kirk, MC; Montgomery, JA; Shortnacy, AT; Struck, RF; Thorpe, MC | 1 |
| Fabianowska-Majewska, K; Wyczechowska, D | 1 |
| Adjei, AA; Dagnino, L; Paterson, AR; Wong, MM | 1 |
| Barrueco, JR; Brockman, RW; Chang, CH; Jacobsen, DM; Sirotnak, FM | 1 |
| Bacon, PE; Brown, NC; Carter, GL; Cory, JG; Montgomery, JA; Sato, A | 1 |
12 other study(ies) available for fludarabine and Leukemia L 1210
| Article | Year |
|---|---|
2-Fluoroformycin and 2-aminoformycin. Synthesis and biological activity.
Topics: Adenosine; Adenosine Deaminase; Animals; Antibiotics, Antineoplastic; Formycins; Kinetics; Leukemia L1210; Nucleotides; Phosphates; Substrate Specificity | 1985 |
Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Hydrazines; Injections, Intraperitoneal; Leukemia L1210; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Sulfonamides; Survival Analysis; Time Factors; Tumor Burden; Vidarabine; Weight Loss; Xenograft Model Antitumor Assays | 2007 |
Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
Topics: Animals; Cell Line; Chromatography, DEAE-Cellulose; Deoxycytidine Kinase; DNA; Electrophoresis, Polyacrylamide Gel; Leukemia L1210; Mice; Mutation; Oxidative Phosphorylation; Phosphotransferases; Vidarabine | 1980 |
Synergistic inhibition of leukemia L1210 cell growth in vitro by combinations of 2-fluoroadenine nucleosides and hydroxyurea or 2,3-dihydro-1H-pyrazole[2,3-a]imidazole.
Topics: Animals; Cell Survival; Cytidine; Deferoxamine; Deoxyadenosines; Deoxycytidine; Drug Synergism; Hydroxyurea; Kinetics; Leukemia L1210; Mice; Pyrazoles; Vidarabine | 1984 |
Specificity of systems mediating transport of adenosine, 9-beta-d-arabinofuranosyl-2-fluoroadenine, and other purine nucleoside analogues in L1210 cells.
Topics: Adenosine; Animals; Biological Transport; Kinetics; Leukemia L1210; Mice; Purine Nucleosides; Temperature; Time Factors; Vidarabine | 1983 |
Initial rate kinetics and evidence for duality of mediated transport of adenosine, related purine nucleosides, and nucleoside analogues in L1210 cells.
Topics: Adenosine; Animals; Biological Transport; Cell Membrane; Kinetics; Leukemia L1210; Mice; Purine Nucleosides; Temperature; Time Factors; Vidarabine | 1983 |
Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
Topics: Adenosylhomocysteinase; Animals; DNA Polymerase I; DNA Polymerase II; DNA Replication; Hydrolases; Leukemia L1210; Mice; Nucleic Acid Synthesis Inhibitors; Ribonucleotide Reductases; Vidarabine | 1982 |
Identification of metabolites of 9-beta-D-arabinofuranosyl-2-fluoroadenine, an antitumor and antiviral agent.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Chemical Phenomena; Chemistry; Dogs; Female; Leukemia L1210; Macaca mulatta; Male; Mice; Vidarabine | 1982 |
Does 2-chlorodeoxyadenosine contribute to alteration of DNA methyltransferase activity?
Topics: Adenosylhomocysteinase; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Cladribine; Decitabine; DNA (Cytosine-5-)-Methyltransferases; Hydrolases; Kinetics; Leukemia L1210; Mice; Tumor Cells, Cultured; Vidarabine | 1998 |
Protection against fludarabine neurotoxicity in leukemic mice by the nucleoside transport inhibitor nitrobenzylthioinosine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Female; Hindlimb; Leukemia L1210; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Nervous System Diseases; Paralysis; Prodrugs; Thioinosine; Thionucleotides; Vidarabine | 1992 |
Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
Topics: Animals; Biological Transport; Epithelium; Intestine, Small; Kinetics; Leukemia L1210; Mice; Mice, Inbred Strains; Organ Specificity; Phosphorylation; Tritium; Vidarabine | 1987 |
The utility of combinations of drugs directed at specific sites of the same target enzyme--ribonucleotide reductase as the model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cells, Cultured; Deoxyadenosines; Deoxyguanosine; Hydroxyurea; Isoquinolines; Leukemia L1210; Models, Biological; Nucleic Acid Synthesis Inhibitors; Phosphorylases; Pyrazoles; Ribonucleoside Diphosphate Reductase; Ribonucleotide Reductases; Thymidine; Vidarabine | 1985 |